← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Gem Pharmaceuticals, Llc
Birmingham, AL
$1,036,453
Total funding
4
Grants
Funding mix
By agency
NIH$1,036,453 · 4
By mechanism
R42$557,528 · 1
R41$478,925 · 3
Investigators at Gem Pharmaceuticals, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel Doxorubicin Analogs:Cardiac and Cytotoxic Effects$278,764
R42 · FY2002 · HL
Novel Doxorubicin Analogs:Cardiac and Cytotoxic Effects$278,764
R42 · FY2003 · HL
Cardiac Interactions of New Adriamycin Analogs and Taxol$195,590
R41 · FY2004 · HL
Utility of a Novel Anthracycline Analog in Psoriasis$149,052
R41 · FY2005 · AR
NOVEL DOXORUBICIN ANALOGS: CARDIAC AND CYTOTOXIC EFFECTS$134,283
R41 · FY2000 · HL